Market Place
Sourcing Support
Faeth Therapeutics` $92M Fuel PIKTOR Phase 2 For 80% RR in Cancer
27 Oct 2025 //
BUSINESS WIRE
Faeth Raises $92M For Ph2 PIKTOR In Endometrial Cancer
20 Oct 2025 //
PHARMIWEB
Faeth Therapeutics` Phase 2 DICE Trial Reveals 34% Lower Disease
19 Oct 2025 //
PHARMIWEB
Faeth Therapeutics Validates R&d Platform Across Diseases Beyond
30 Sep 2025 //
BUSINESSWIRE
Faeth Therapeutics Presents Positive Phase 2 Ovarian Cancer Data
24 Sep 2025 //
BUSINESSWIRE
Faeth Therapeutics Demonstrates Cancer Treatment in Publication
13 May 2025 //
BUSINESSWIRE
Faeth Therapeutics and GOG Foundation Launch Phase 2 Trial
12 Mar 2025 //
BUSINESSWIRE
Faeth Therapeutics Appoints Dr. Stephen To Board Of Directors
22 Nov 2024 //
BUSINESSWIRE
Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase
17 Jul 2024 //
BUSINESSWIRE
Faeth Therapeutics to Participate in the Stifel 2023 Healthcare Conference
08 Nov 2023 //
BUSINESSWIRE
Faeth Announces Medicine Recognition for Dr. Siddhartha Mukherjee
13 Oct 2023 //
BUSINESSWIRE
Faeth Appoints Debbie Chirnomas, M.D., M.P.H., as Chief Medical Officer
29 Sep 2023 //
BUSINESSWIRE
Faeth Tx Appoints Thomas Strack as CMO, Virginia Casadas as Head of Operations
11 Apr 2022 //
BUSINESSWIRE
Faeth Therapeutics Raises $20M to Advance Precision Nutrition
18 Jan 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.